Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations

Background: Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of death by cancer worldwide. Mostly diagnosed with locally advanced or metastatic disease, patients lack treatment options. Gene alterations (GAs) are frequently observed in PDAC, some of which are considered for molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarabay, Anthony, Boileve, Alice, Smolenschi, Cristina, Antoun, Leony, Valery, Marine, Fuerea, Alina, Perret, Audrey, Burtin, Pascal, Cosconea, Simona, Belkhodja, Hichem, Malka, David, Boige, Valérie, Hollebecque, Antoine, Ducreux, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526242/
https://www.ncbi.nlm.nih.gov/pubmed/37761010
http://dx.doi.org/10.3390/biomedicines11092569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526242/
https://www.ncbi.nlm.nih.gov/pubmed/37761010
http://dx.doi.org/10.3390/biomedicines11092569

Ejemplares similares